Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
03/2003
03/20/2003US20030054198 Image display device
03/20/2003US20030054038 Mixture of drug and enteric acid polymer; neutralization
03/20/2003CA2456614A1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
03/19/2003EP1292575A2 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
03/19/2003EP0931070B1 Hetaroyl cyclohexanedione derivatives with herbicidal effect
03/19/2003EP0900203B1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/18/2003US6534535 Inhibitors of factor Xa
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534491 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
03/18/2003US6534201 Organometallic luminescent materials and organic electroluminescent device containing same
03/18/2003CA2362944C Optical isomers of ¬3-(1,1-dialkylated)-1-aminomethyl-pyrrolidine|
03/18/2003CA2236239C Quinoline and quinazoline compounds useful in therapy
03/18/2003CA2162708C Bicyclic amide derivatives and their use as muscle relaxants
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002074726A3 Aniline derivatives useful as phosphodiesterase 4 inhibitors
03/13/2003WO2002045703A3 Mixtures or organic compounds for the treatmentof airway diseases
03/13/2003WO2002013797A3 Therapeutic combination of a cetp inhibitor and atorvastatin
03/13/2003US20030050475 Contacting a 5 or 6-methyl quinoxaline with a halogenating agent in the presence of radical initiator in solvent (mono,di,tri fluoro or chlorobenzenes or a,trichloro or fluorotoluene to form 5 or 6- halomethylquinoxaline
03/12/2003WO2002024654A1 Amino heterocyclic compounds (factor xa inhibitors 14)
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1291344A1 Rice blast control agents
03/12/2003EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1012144B1 Method for producing (hetero)aromatic hydroxylamines
03/12/2003CN1402722A Arylamine derivs. and their use an anti-telomerase
03/12/2003CN1402711A 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as CETP inhibitor
03/12/2003CN1401637A Process for preparing norfloxacin silver as antiinfection medicine for burns
03/12/2003CA2422067A1 Aminoheterocycles (factor xa inhibitors 14)
03/11/2003US6531599 Compounds having activity as inhibitors of cytochrome P450RAI
03/11/2003US6531424 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical
03/11/2003CA2121230C 1,3-dihydro-2h-imidazo(4,5-b) quinolin-2-one derivatives
03/11/2003CA2056793C 5-amino-5,6,7,8-tetrahydroquinolines and related compounds a process for their preparation and their use as medicaments
03/06/2003WO2003018561A1 N-type calcium channel antagonists for the treatment of pain
03/06/2003WO2003018560A1 N-type calcium channel antagonists for the treatment of pain
03/06/2003WO2003018558A1 Environment-sensitive luminescent dimine-platinum binuclear complexes
03/06/2003WO2003017765A1 Treatment for cystic fibrosis
03/06/2003WO2003017764A1 Substituted propargylamines
03/06/2003WO2002094770A3 Aminoalcohol derivatives
03/06/2003WO2002024672A3 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045525 Particularly in the treatment of benign prostatic hyperplasia.
03/05/2003EP1286955A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
03/05/2003EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/05/2003CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
03/05/2003CN1400969A Fused imidazolium derivatives
03/04/2003US6528661 Providing atorvastatin ester derivative; converting the atorvastatin ester derivative to atorvastatin hemi-calcium with calcium hydroxide
03/04/2003US6528655 Aromatic derivatives with HIV integrase inhibitory properties
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
03/04/2003US6528526 Inhibition of cell proliferation and/or cell matrix production and/or cell movement (chemotaxis) and/or T cell activation and proliferation
03/04/2003US6528525 Amidocarboxylic acid derivatives
03/04/2003US6528187 Luminescence element comprising pair of electrodes having formed therebetween plurality of organic compound thin film layers comprising electron-transporting layer which comprises specified compound
03/03/2003WO2002020491A1 Arylpiperazine derivatives and their use as psychotropic agents
03/03/2003CA2421219A1 Arylpiperazine derivatives and their use as psychopharmaceuticals
02/2003
02/27/2003WO2003016317A1 Processes for preparing calcium salt forms of statins
02/27/2003WO2003016267A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
02/27/2003WO2002092602A3 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE
02/27/2003WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof
02/27/2003WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
02/26/2003EP1285651A1 Melanin concentrating hormone antagonists
02/26/2003EP0876348B1 Salts of quinoline derivatives as nk3 antagonists
02/25/2003US6525215 HIV protease inhibitors
02/25/2003US6525201 Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide
02/25/2003US6525085 Diaryl-enynes
02/25/2003US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
02/25/2003US6525067 Substituted heterocyclic derivatives
02/25/2003US6525042 Sulfonyl derivatives
02/25/2003US6525036 Compounds and compositions as protease inhibitors
02/25/2003US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders
02/25/2003US6524347 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
02/21/2003WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/21/2003CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/20/2003WO2003014075A2 Novel gamma secretase inhibitors
02/20/2003WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
02/20/2003WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
02/20/2003WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
02/20/2003WO2002088069A3 Compounds useful as intermediates for 4-aminoquinoline derivatives
02/20/2003WO2002049993A3 High affinity small molecule c5a receptor modulators
02/20/2003WO2002024635A3 Aminoalcohol derivatives
02/20/2003CA2456103A1 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives
02/20/2003CA2455754A1 Amine derivatives
02/19/2003EP1283827A2 Caspase inhibitors and uses thereof
02/19/2003EP1283711A1 Peptide deformylase inhibitors
02/19/2003EP0944603B1 Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives
02/19/2003CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives
02/19/2003CN1398252A Dehydroamino acids compounds
02/18/2003US6521755 Process for preparing 10,11-methanobenzosuberane derivatives
02/18/2003US6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
02/18/2003US6521618 Antineoplastic agents, agents for treatment of osteoporosis and polycystic kidney disease
02/18/2003US6521603 Fungicides for the control of take-all disease of plants
02/14/2003WO2002018326A1 Novel propenohydroxamic acid derivatives
02/14/2003CA2423733A1 Novel propenohydroxamic acid derivatives
02/13/2003WO2003011832A1 Quinoline derivatives and use thereof as antitumor agents
02/13/2003WO2003011819A1 Butyric acid derivatives
02/13/2003WO2003011814A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc
02/13/2003WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME
02/13/2003WO2003011292A1 Antivesicant compounds and methods of making and using thereof
02/13/2003WO2002046163A3 Quinoline derivatives and their use as anti-epileptics
02/13/2003WO2002015942A8 Method for the identification of agents that inhibit or promote cataracts and uses thereof
02/13/2003US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase
02/13/2003US20030032623 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis.
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 277